Table 1.

A summary of the different studies investigating the use of steroid tape in non-scar, dermatological patients categorised based on the Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party levels 1–5.⁶

Authors	Type of study/Level of evidence	Disease	Patient no.	Age range (years)	Steroid	Total body surface area	Daily duration of application	Duration of treatment	Symptomatic response
Labow TA et al., 196931	Double-blinded controlled trial- 1	Psoriasis	21 (32 sites treated with steroid tape and 38 with placebo)	Unspecified range; median: 51 years	Flurandrenolone tape (4 μg/cm2)	Four sites treated per patient (two with active tape and two with placebo)	24 h	2 weeks (2 dropouts)	26/32 steroid tape vs. 6/38 placebo sites showed overall improvement (P <0.001)
Kikuchi I and Jono M, 197632	Case series – 4	Granuloma gluteale infantum	2	3- and 6-month-old	0.025% fluocinolone acetonide (case 1) and flurandrenolide tape (case 2)	Unspecified	1–2 months of daily application (case 1), unspecified (case 2)	1–2 months (case 1); unspecified (case 2)	Good response (noticeable flattening of lesions)
Berger JE and Helm F, 197010	Case series– 4	Range of subacute and chronic dermatoses	155	Unspecified	Flurandrenolone tape (4μg/cm2)	Areas of 1–24 inches in maximum dimension	3–24 h daily	1 day to 6 weeks	61/155 showed good results and 38/155 moderate results
Gomez F and Schorr WF, 196833	Case series– 4	Dermatoses including psoriasis, lichen, contact dermatitis	42	Unspecified	Flurandrenolone tape (4μg/cm2)	Unspecified	24 h	3 weeks (one dropout at day 6)	36/42 showed excellent to good results
Riley K, 196918	Case series– 4	Dermatoses including psoriasis, lichen disorders	39	8–77 years	Flurandrenolone tape (4μg/cm2)	Maximum dimension 4 inches	Night-time or 24 h on–24 h off regimen	Unspecified	28/39 showed good to excellent results, 7 partial improvement
Burrows D, 196934	Case series– 4	Dermatoses including lupus erythematosus, psoriasis, lichen disorders	41	Unspecified	Flurandrenolone tape (4μg/cm2)	Less than 10% of total body surface area	12–24 h	Unspecified	19/41 obtained clearance of lesions and 12/41 showed improvement
Sellers FM, 197035	Case series – 4	Psoriasis and lichen simplex/ planus	15	Unspecified	Flurandrenolone tape (4 μg/cm2)	Unspecified	12 h	Unspecified	All patients reported improvement
Ronchese F, 196936	Case series – 4	Dermatoses including lichen chronicus, psoriasis	126	Unspecified	Flurandrenolone tape (4μg/cm2)	Unspecified	Bedtime	Unspecified	Poor reporting of outcomes but positive descriptive data provided
Nurse DS, 197437	Case series – 4	Dermatoses including, psoriasis and eczema	172	Unspecified	Flurandrenolone tape (4μg/cm2)	Unspecified	Unspecified	2–63 days	Excellent results in 63 patients and good results in 60 patients
Fields RJ and Magpantay R, 196838	Case series – 4	Dermatoses including psoriasis, eczema, contact dermatitis	56	Unspecified	Flurandrenolone tape (4μg/cm2)	Unspecified	Overnight-24 h	Unspecified	Excellent response in 15/56 and good in 29/56 patients
Boatwright H, 196939	Case series– 4	Dermatoses including lichen, atopic/contact dermatitis, lupus erythematosus	915	Unspecified	Flurandrenolone tape (4μg/cm2)	Unspecified	Unspecified	Unspecified	Excellent response in 42.19%, good response in 30.27% and partial improvement in 14.86%
Kestel JL, 197140	Case report – 4	Neurodermatitis	1	14	Flurandrenolone tape (4μg/cm2)	Unspecified	Overnight	Unspecified	Good response
Azulay DR, 198541	Case report– 4	Isotretinoin associated granulation tissue	1	Unspecified	Flurandrenolide tape	Unspecified	Unspecified	Unspecified	Good response
Ronchese F, 197442	Case report– 4	Recurrent periungual myxoid cysts	5	Unspecified	Flurandrenolone tape (4μg/cm2)	Small area corresponding to periungual myxoid cysts	Cycle of 24 h tape application followed by 24 h of steroid cream	2–3 months	Excellent response with no recurrence for up to 3 years